[Subacute Budd-Chiari syndrome treated with rTPA. Considerations on a case].
The authors report on a case of hepatic vein thrombosis or Budd-Chiari syndrome (BCS) successfully treated with recombinant Tissue Plasminogen Activator (rTPA). They briefly outline the etiology and symptomatology of this disease as well as the various surgical procedures used for treatment. Medical therapy has been so far poorly effective in treatment BCS, but recently various reports seem to indicate that rTPA may have a role. The authors suggest that rTPA may be used as the only therapy in selected cases, or in treating patients that are not candidates for surgical intervention, or as a temporizing measure to improve symptoms in patients awaiting surgery.
Nardini
A
A
II Divisione di Chirurgia Generale, Ospedale Civile Sant'Andrea, La Spezia.
Falco
E
E
Celoria
G
G
Neviani
A L
AL
Stefani
R
R
Gadducci
G
G
Astesana
L
L
Spinetta
G
G
D000208:Acute Disease; D006502:Budd-Chiari Syndrome / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator
Sindrome di Budd-Chiari subacuta trattata con rTPA. Considerazioni a proposito di un caso.